- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Vanderbilt-Ingram Cancer Center
Total 1407 results
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedLung Cancer | Healthy, no Evidence of DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedLung CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedPain | Arthralgia | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphoma | Myelodysplastic Syndromes | Leukemia | Myeloproliferative Disorders | Solid Tumor | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Nausea and Vomiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck Cancer
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Breast Cancer | FatigueUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedLiver CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States, Canada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedHead and Neck Cancer | Metastatic Cancer | Pheochromocytoma | Islet Cell TumorUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Lung Cancer | Peritoneal Cavity Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Cardiovascular ComplicationsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Solid TumorUnited States
-
Michael K. GibsonRecruitingRecurrent Oropharyngeal Carcinoma | Metastatic Oropharyngeal CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEntrinsic Bioscience Inc.TerminatedNeuroendocrine Tumor | Carcinoid SyndromeUnited States
-
Vanderbilt-Ingram Cancer CenterWren Laboratories LLCCompletedMelanomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Vanderbilt-Ingram Cancer CenterCompletedLung CancerUnited States
-
Vanderbilt-Ingram Cancer CenterKite, A Gilead CompanyActive, not recruitingDiffuse Large B-cell Lymphoma | Large B-cell LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterMerck Sharp & Dohme LLCRecruitingLimited Stage Lung Small Cell Carcinoma | Stage III Lung Cancer | Stage I Lung Cancer | Stage II Lung CancerUnited States
-
A Bapsi Chakravarthy, MDCompletedResistant Breast Cancer | Non-metastatic Invasive Breast CancerUnited States
-
Andreana Holowatyj, PhD, MSCIRecruitingAppendix Cancer | Appendiceal Neoplasms | Appendix Adenocarcinoma | Appendiceal Cancer | Appendiceal Adenocarcinoma | Appendix Tumor | Appendiceal Mucinous Neoplasm | Appendiceal Carcinoid Tumor | Appendiceal Neoplasm Malignant Secondary | Appendix Mucinous Neoplasm | Appendix Cancer Metastatic | Appendix NET | Low-Grade Appendix Mucinous Neoplasm and other conditionsUnited States
-
Douglas JohnsonIncyte CorporationRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Andreana Holowatyj, PhD, MSCIRecruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); EMD SeronoTerminated
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.; Stand Up To CancerTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Estrogen Receptor-positiveUnited States
-
Debra FriedmanNational Cancer Institute (NCI)Active, not recruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States
-
Debra FriedmanNational Cancer Institute (NCI)Recruiting
-
Laura KennedyNational Cancer Institute (NCI)SuspendedBreast Cancer | Triple-negative Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkWithdrawnSquamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma of the Head or Neck | Metastatic Squamous Cell Carcinoma of the Head or Neck
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)RecruitingHead and Neck Squamous Cell Carcinoma | Brain MetastasesUnited States
-
Vanderbilt-Ingram Cancer CenterUnited States Department of DefenseRecruitingRenal Cell CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States